U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06974539) titled 'TULIP ReTrain Study' on May 08.
Brief Summary: This prospective clinical study aims to retrain and validate the PCaVision AI algorithm for the detection and localization of clinically significant prostate cancer (csPCa) using multiparametric ultrasound (mpUS) with two different ultrasound contrast agents: Sonovue and Optison. Data will be collected using a commercial version of the LOGIQ E10 ultrasound machine, with full histopathological correlation in patients undergoing radical prostatectomy.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Intervention:
DIAGNOSTIC_TEST: Multiparametric ultr...